Bmp2 – Targeting the ubiquitin–proteasome system for cancer therapy

Copyright : ? 2015 Laukkanen et al. pathway activation represents the

December 8, 2018 by Katherine Lewis Leave a Comment

Copyright : ? 2015 Laukkanen et al. pathway activation represents the original tumorigenic event, whereas in various other individual malignancies, including gastrointestinal, lung, human brain, breasts and prostate malignancies, deregulation of Hh signaling takes place during tumor development and participates in tumor maintenance. Scientific tests using molecular inhibitors focusing on Hh pathway parts, specifically the … [Read more…]

Receptor activator of NF-B ligand (Rankl) is a TNF-like factor that

February 15, 2018 by Katherine Lewis Leave a Comment

Receptor activator of NF-B ligand (Rankl) is a TNF-like factor that induces the formation of osteoclasts responsible for bone resorption. suggesting a role for both factors in the control of enhancer-mediated Rankl transcription. Finally, chromosome conformation capture analysis confirmed that mRL-D5 and segments of the TCCR were located in proximity to the Rankl gene promoter … [Read more…]